Concepedia

Nadja Uhlig

NU

Statistics

Publications

9

Citations

405

H-Index

9

Active since

2021

Affiliations

Fraunhofer Institute for Cell Therapy and Immunology(Current)

Institute of Medical Microbiology and Hygiene

University of Göttingen

Friedrich-Alexander-Universität Erlangen-Nürnberg

Goethe University Frankfurt

Nadja Uhlig is an author at Fraunhofer Institute for Cell Therapy and Immunology specializing in medicine, virology, and immunology.

ORCID

Top concepts

Publications per year

2021–2023

9

Publications

9

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

Dennis Lapuente, Jana Fuchs, Jonas Willar et al. · Nature Communications · 2021 · 213 citations · Full text

A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections

Christian Gege, Fernando Bravo, Nadja Uhlig et al. · Science Translational Medicine · 2021 · 48 citations

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

Kim M. Stegmann, Antje Dickmanns, Natalie Heinen et al. · iScience · 2022 · 38 citations · Full text

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model

Antonia Sophia Peter, Edith Roth, Sebastian Schulz et al. · European Journal of Immunology · 2021 · 29 citations · Full text

, , +14

Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model

Nadja Uhlig, Anne-Kathrin Donner, Christian Gege et al. · Antiviral Research · 2021 · 20 citations · Full text

, , +18

Rows per page

1–5 of 9